Cc Trial Jun 2026

: Five-year survival data from this trial showed that while SOX offered a potent treatment path, the 3-year DFS rate for patients was approximately 71.5% in the SOX group compared to 65% in the UFT/LV group.

The cc trial demonstrated that [Product/Service] is [effective/safe] for [specific condition or population]. These findings are consistent with previous studies and support the use of [Product/Service] as a [potential treatment option]. cc trial

A. Researcher¹, B. Clinician² ¹University of Medical Sciences, ²City General Hospital : Five-year survival data from this trial showed